Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages.
about
The structure and function of human IgAPseudomonas aeruginosa-induced lung and pleural injury in sheep. Differential protective effect of circulating versus alveolar immunoglobulin G antibody.Interaction of alveolar macrophages with Nocardia asteroides: immunological enhancement of phagocytosis, phagosome-lysosome fusion, and microbicidal activity.Kinetics of phagocytosis of Staphylococcus aureus by alveolar and peritoneal macrophages.Effect of alveolar macrophages on Toxoplasma gondiiProteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosisIn vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharideStimulation by fibronectin of macrophage-mediated phagocytosis of Pseudomonas aeruginosa.Therapeutic effects of a human antiflagella monoclonal antibody in a neutropenic murine model of Pseudomonas aeruginosa pneumonia.Effects of the combination of lipopolysaccharide-specific monoclonal antibodies and sparfloxacin against Pseudomonas aeruginosa pneumonia in neutropenic miceLung inflammation and fibrosis: an alveolar macrophage-centered perspective from the 1970s to 1980s.Hydrogen peroxide and superoxide release by alveolar macrophages from normal and BCG-vaccinated guinea-pigs after intravenous challenge with Mycobacterium tuberculosis.Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.Subpopulations of human peripheral granulocyes and monocytes express receptors for IgADifferences in phagocytosis and killing by alveolar macrophages from humans, rabbits, rats, and hamsters.Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients.Effect of pyocyanine, a pigment of Pseudomonas aeruginosa, on production of reactive nitrogen intermediates by murine alveolar macrophages.Resistance of mucoid Pseudomonas aeruginosa to nonopsonic phagocytosis by alveolar macrophages in vitroCystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assayAlveolar macrophage-derived chemotactic factor: kinetics of in vitro production and partial characterization.Use of monoclonal antibodies to protein F of Pseudomonas aeruginosa as opsonins for phagocytosis by macrophages.Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patientsAntibody-dependent cell-mediated antibacterial activity of human mononuclear cells. I. K lymphocytes and monocytes are effective against meningococi in cooperation with human imune sera.Pseudomonas aeruginosa pili as ligands for nonopsonic phagocytosis by fibronectin-stimulated macrophages.Nonopsonic phagocytosis of strains of Pseudomonas aeruginosa from cystic fibrosis patients.Appearance of specific antibody-bearing cells in human bronchial mucosa after local immunization with bacterial vaccine.Pseudomonas aeruginosa cytotoxin: periplasmic localization and inhibition of macrophages.Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs.Antibody-dependent mononuclear cell-mediated antimeningococcal activity. Comparison of the effects of convalescent and postimmunization immunoglobulins G, M, and A.Toxicity of Pseudomonas aeruginosa exotoxin A for human macrophages.Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa.Surface morphology and function of human pulmonary alveolar macrophages from smokers and non-smokers.IgA-dependent, monocyte-mediated, antibacterial activity.Inhibition of phagocytosis and glucose metabolism of alveolar macrophages during pulmonary tumour growth.Various approaches to clinically related research can yield helpful insight. A personal perspective.Deficient intracellular killing of bacteria by murine alveolar macrophages.Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.
P2860
Q24307588-1F1478DA-7AB5-4935-8339-EAFCB04B0E8CQ33901457-A48EA45B-C693-4B87-8DBD-0E21805C798AQ33910909-8C9D53CD-0E13-4C19-A17C-7F0FD92330CFQ34096780-781F9D39-12EE-4ACB-A685-73152B81D455Q34420815-6A1462C3-098D-4A2F-81D9-9FC610650D81Q34612136-48A7DE77-866A-45D2-8B6A-F99F4296920EQ35089066-849533AB-9032-41E2-A0B3-3F1C36F0DB55Q35092429-E0B7F2D0-811E-49D0-9CE3-0A0BC4E6B65AQ35808176-7BE41703-D01F-43AA-82F9-22C3FEA8E610Q35884669-F310A650-0F42-4320-9C31-411B446D8F17Q35959091-EF8AE575-F31E-45C7-BB44-E91E1701E69CQ36091567-4D3B8685-AF57-40AC-9394-C0CACE7DC534Q36093118-0F1E9023-A886-49A6-9DD6-D32A177F3F40Q36394850-5E62F8F2-A8F9-4C79-9C8E-392E3F75DB3EQ36440794-3D5CB597-EE09-4A6D-8F7D-73FE988B632FQ36637394-1F08C2DF-9F98-464C-9302-FCFEFEA5F106Q36951075-1949A2A1-6A51-43D5-8186-130E3CB6F36FQ37002223-953AC3B0-70B1-4C77-97EF-D7FB773306D2Q37004057-1D2BFAE5-D351-4A36-A814-757437060662Q37019905-B9777842-57DA-4F85-906B-FF9020A5B05CQ37024316-85692418-95AB-4239-ABB5-2AE9610DF655Q37208228-CAC9CCC4-1249-421F-B769-54951238DC09Q39666286-4BDB01B3-F4E8-4055-AED2-E32AFCFE18C4Q40160354-B961DB30-4E10-4623-AB27-A2BEFD2A7D61Q40181601-CF3BC11A-BF58-4AC9-A600-835E1A929111Q40206035-7422EC21-566C-4F28-8210-27F068061F49Q40426470-F4CA4C26-F1AD-466E-99B2-8B1BCBDE3289Q40684350-ACD7B54D-6E7E-4242-A5EA-693A62031171Q40688162-23B86F77-53BB-4009-8A2F-B7E782564A53Q40912617-01AEE70E-7222-4F9A-A72B-01FED9C0701DQ41065563-3CC7C5AA-F8ED-40F3-9BF4-4E566D684CF5Q41121765-C0EF62F3-5635-4596-BF21-CFB947C5A898Q41829756-DC655641-4E09-40B8-BED2-4CB25700E456Q42578900-5A21256C-03D4-4860-AB36-957C5AC9A047Q44313836-72128A50-57E7-445B-81CF-E72B5A349E34Q44984317-18533FAE-55E2-4E6A-8AB4-A7502B50675DQ52448914-94BC9819-496D-4AB7-B3D7-97F8AF41B9D8
P2860
Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages.
description
1975 nî lūn-bûn
@nan
1975 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Specificity of opsonic antibod ...... by human alveolar macrophages.
@ast
Specificity of opsonic antibod ...... by human alveolar macrophages.
@en
type
label
Specificity of opsonic antibod ...... by human alveolar macrophages.
@ast
Specificity of opsonic antibod ...... by human alveolar macrophages.
@en
prefLabel
Specificity of opsonic antibod ...... by human alveolar macrophages.
@ast
Specificity of opsonic antibod ...... by human alveolar macrophages.
@en
P2093
P2860
P921
P356
P1476
Specificity of opsonic antibod ...... by human alveolar macrophages.
@en
P2093
Kazmierowski JA
Newball HH
Reynolds HY
P2860
P304
P356
10.1172/JCI108102
P407
P577
1975-08-01T00:00:00Z